As of 2025-07-19, the EV/EBITDA ratio of Beijing Science Sun Pharmaceutical Co Ltd (300485.SZ) is -164.59. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 300485.SZ's latest enterprise value is 6,537.31 mil CNY. 300485.SZ's TTM EBITDA according to its financial statements is -39.72 mil CNY. Dividing these 2 quantities gives us the above 300485.SZ EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 23.6x - 29.3x | 26.3x |
| Forward P/E multiples | 10.7x - 20.5x | 15.8x |
| Fair Price | (1.80) - 1.51 | (0.41) |
| Upside | -113.1% - -89.0% | -103.0% |
| Date | EV/EBITDA |
| 2025-07-10 | -167.26 |
| 2025-07-09 | -172.48 |
| 2025-07-08 | -171.75 |
| 2025-07-07 | -170.29 |
| 2025-07-04 | -176.36 |
| 2025-07-03 | -181.57 |
| 2025-07-02 | -164.23 |
| 2025-07-01 | -166.41 |
| 2025-06-30 | -164.23 |
| 2025-06-27 | -159.26 |
| 2025-06-26 | -155.01 |
| 2025-06-25 | -161.20 |
| 2025-06-24 | -172.23 |
| 2025-06-23 | -162.89 |
| 2025-06-20 | -167.26 |
| 2025-06-19 | -139.13 |
| 2025-06-18 | -152.47 |
| 2025-06-17 | -152.34 |
| 2025-06-16 | -166.65 |
| 2025-06-13 | -164.23 |
| 2025-06-12 | -152.10 |
| 2025-06-11 | -157.68 |
| 2025-06-10 | -153.19 |
| 2025-06-09 | -127.36 |
| 2025-06-06 | -119.96 |
| 2025-06-05 | -121.42 |
| 2025-06-04 | -125.66 |
| 2025-06-03 | -128.33 |
| 2025-05-30 | -125.91 |
| 2025-05-29 | -121.90 |
| 2025-05-28 | -111.60 |
| 2025-05-27 | -117.66 |
| 2025-05-26 | -113.17 |
| 2025-05-23 | -114.75 |
| 2025-05-22 | -117.05 |
| 2025-05-21 | -132.70 |
| 2025-05-20 | -113.78 |
| 2025-05-19 | -104.32 |
| 2025-05-16 | -101.41 |
| 2025-05-15 | -97.53 |
| 2025-05-14 | -96.80 |
| 2025-05-13 | -96.80 |
| 2025-05-12 | -96.07 |
| 2025-05-09 | -97.53 |
| 2025-05-08 | -98.74 |
| 2025-05-07 | -96.92 |
| 2025-05-06 | -97.65 |
| 2025-04-30 | -96.56 |
| 2025-04-29 | -96.20 |
| 2025-04-28 | -96.20 |